Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza Season-Reference-Cited by-同舟云学术

Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza Season

Published:2015-07 Issue:1 Volume:12 Page:1-6
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Chambers Benjamin S.,Parkhouse Kaela,Ross Ted M.,Alby Kevin,Hensley Scott E.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference15 articles.

1. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin;Abe;J. Virol.,2004

2. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season;Anonymous;Wkly. Epidemiol. Rec.,2015

3. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype;Broberg;Euro Surveill.,2015

4. Update: influenza activity - United States, september 28, 2014-february 21, 2015;D’Mello;MMWR Morb. Mortal. Wkly. Rep.,2015

5. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015;Flannery;MMWR Morb. Mortal. Wkly. Rep.,2015

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin;Cell Host & Microbe;2024-08

2. Resurgence of influenza with increased genetic diversity of circulating viruses during the 2022–2023 season;Journal of Medical Microbiology;2024-07-29

3. MetaFluAD: meta-learning for predicting antigenic distances among influenza viruses;Briefings in Bioinformatics;2024-07-25

4. Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations;Journal of Medical Virology;2024-06

5. Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled Trial;2024-05-17